Back
OptimizeRx Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
25
OPRX
OptimizeRx
Last Price:
$12.88
Seasonality Move:
-0.35%
7 Day Trial
ALL ACCESS PASS
$
7

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bearish and OPRX is experiencing selling pressure, which indicates risk of future bearish movement.
OptimizeRx Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.14 | Sell |
20-day SMA: | 13.44 | Sell |
50-day SMA: | 11.04 | Buy |
200-day SMA: | 7.38 | Buy |
8-day EMA: | 13.64 | Sell |
20-day EMA: | 13.24 | Sell |
50-day EMA: | 11.5 | Buy |
200-day EMA: | 8.92 | Buy |
OptimizeRx Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.77 | Buy |
Relative Strength Index (14 RSI): | 50.74 | Buy |
Chaikin Money Flow: | -180869 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.76 - 14.36) | Sell |
Bollinger Bands (100): | (5.87 - 11.77) | Buy |
OptimizeRx Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OptimizeRx Stock
Is OptimizeRx Stock a Buy?
-
OptimizeRx share price is 12.88 while OPRX 8-day simple moving average is 14.14, which is a Sell signal.
-
The stock price of OPRX is 12.88 while OptimizeRx 20-day SMA is 13.44, which makes it a Sell.
-
OptimizeRx 50-day simple moving average is 11.04 while OPRX share price is 12.88, making it a Buy technically.
-
OPRX stock price is 12.88 and OptimizeRx 200-day simple moving average is 7.38, creating a Buy signal.
OPRX Technical Analysis vs Fundamental Analysis
Sell
25
OptimizeRx (OPRX)
is a Sell
Is OptimizeRx a Buy or a Sell?
-
OptimizeRx stock is rated a SellThe current OptimizeRx [OPRX] share price is $12.88. The Score for OPRX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
OptimizeRx Stock Info
Market Cap:
238.2M
Price in USD:
12.88
Share Volume:
196.6K
OptimizeRx 52-Week Range
52-Week High:
15.71
52-Week Low:
3.78
Sell
25
OptimizeRx (OPRX)
is a Sell
OptimizeRx Share Price Forecast
-
What is the OptimizeRx stock price today?The OptimizeRx stock price is 12.88 USD today.
-
Will OPRX stock go up or go down?OptimizeRx> share price is forecast to RISE/FALL based on technical indicators
-
Is OptimizeRx overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, OptimizeRx is overvalued.
Is OptimizeRx Stock a Buy?
-
OptimizeRx share price is 12.88 while OPRX 8-day exponential moving average is 13.64, which is a Sell signal.
-
The stock price of OPRX is 12.88 while OptimizeRx 20-day EMA is 13.24, which makes it a Sell.
-
OptimizeRx 50-day exponential moving average is 11.50 while OPRX share price is 12.88, making it a Buy technically.
-
OPRX stock price is 12.88 and OptimizeRx 200-day simple moving average is 8.92, creating a Buy signal.
Fundamental Analysis of OptimizeRx
Is OptimizeRx a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.11 per share.
Technical Analysis of OptimizeRx
Should I short OptimizeRx stock?
-
OPRX Moving Average Covergence Divergence (MACD) indicator is 0.77, suggesting OptimizeRx is a Buy
-
OptimizeRx Relative Strength Index (RSI) is 50.74, which suggest OptimizeRx is overbought
-
The Bollinger Bands (25) for OptimizeRx is (11.76 - 14.36), which suggest OptimizeRx is a Buy
-
The Bollinger Bands (100) for OptimizeRx is (5.87 - 11.77), which suggest OptimizeRx is a Buy
* OptimizeRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.